GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Beneish M-Score

Novomics Co (XKRX:283100) Beneish M-Score : -3.11 (As of Jun. 10, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.11 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Novomics Co's Beneish M-Score or its related term are showing as below:

XKRX:283100' s Beneish M-Score Range Over the Past 10 Years
Min: -10.38   Med: -3   Max: 3.07
Current: -3.11

During the past 7 years, the highest Beneish M-Score of Novomics Co was 3.07. The lowest was -10.38. And the median was -3.00.


Novomics Co Beneish M-Score Historical Data

The historical data trend for Novomics Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Beneish M-Score Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - 3.07 -2.89 -10.38 -3.11

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score Get a 7-Day Free Trial - 3.07 -2.89 -10.38 -3.11

Competitive Comparison of Novomics Co's Beneish M-Score

For the Biotechnology subindustry, Novomics Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Novomics Co's Beneish M-Score falls into.



Novomics Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Novomics Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1772+0.528 * 1.5167+0.404 * 1.005+0.892 * 0.9227+0.115 * 0.7776
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7118+4.679 * -0.20919-0.327 * 1.1488
=-3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩68.6 Mil.
Revenue was ₩190.1 Mil.
Gross Profit was ₩42.8 Mil.
Total Current Assets was ₩2,183.4 Mil.
Total Assets was ₩4,542.7 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,142.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩729.1 Mil.
Selling, General, & Admin. Expense(SGA) was ₩891.6 Mil.
Total Current Liabilities was ₩11,052.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₩110.8 Mil.
Net Income was ₩-4,425.8 Mil.
Gross Profit was ₩0.0 Mil.
Cash Flow from Operations was ₩-3,475.6 Mil.
Total Receivables was ₩63.2 Mil.
Revenue was ₩206.0 Mil.
Gross Profit was ₩70.3 Mil.
Total Current Assets was ₩1,978.4 Mil.
Total Assets was ₩4,899.1 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,614.4 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩701.7 Mil.
Selling, General, & Admin. Expense(SGA) was ₩1,357.6 Mil.
Total Current Liabilities was ₩10,088.4 Mil.
Long-Term Debt & Capital Lease Obligation was ₩390.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(68.639 / 190.103) / (63.195 / 206.034)
=0.361062 / 0.306721
=1.1772

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(70.324 / 206.034) / (42.781 / 190.103)
=0.341322 / 0.225041
=1.5167

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2183.357 + 1142.124) / 4542.712) / (1 - (1978.408 + 1614.423) / 4899.07)
=0.267952 / 0.26663
=1.005

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=190.103 / 206.034
=0.9227

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(701.745 / (701.745 + 1614.423)) / (729.138 / (729.138 + 1142.124))
=0.302977 / 0.38965
=0.7776

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(891.621 / 190.103) / (1357.554 / 206.034)
=4.6902 / 6.58898
=0.7118

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((110.79 + 11052.316) / 4542.712) / ((390.829 + 10088.396) / 4899.07)
=2.457366 / 2.139023
=1.1488

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-4425.846 - 0 - -3475.555) / 4542.712
=-0.20919

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Novomics Co has a M-score of -3.11 suggests that the company is unlikely to be a manipulator.


Novomics Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Novomics Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co (XKRX:283100) Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co (XKRX:283100) Headlines

No Headlines